Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00594451 · ClinicalTrials.gov registry record
Gene-Environment Interactions in Rheumatoid Arthritis Autoimmunity Disease Severity
A clinical trial, sponsored by University of Nebraska.
- Completed
- Registry status
- 800
- Enrollment target
NCT00594451: Completed study, sponsored by University of Nebraska.
NCT00594451 is a clinical trial that has completed, run by University of Nebraska. The registered enrollment target is 800 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00594451 has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- 800 participants
- Enrollment target
Study Summary
The objective of the proposed study is to assess the role of smoking and complex gene-smoking interactions in two understudied Rheumatoid Arthritis (RA)groups.
Primary Outcome
Rheumatoid factor (RF) antibody status and concentration. RF is an autoantibody that responds to inflammation caused by RA.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2006-10-19 |
| Est. Completion | 2013-01-01 |
What the finished NCT00594451 record still lists
NCT00594451 is an observational study that tracks outcomes without assigning an intervention. The registered 800 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00594451 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00594451 about?
NCT00594451 is a clinical study titled "Gene-Environment Interactions in Rheumatoid Arthritis Autoimmunity Disease Severity". The objective of the proposed study is to assess the role of smoking and complex gene-smoking interactions in two understudied Rheumatoid Arthritis (RA)groups.
What is the current status of trial NCT00594451?
This trial is currently completed. The enrollment target is 800 participants. The study started on 2006-10-19. Estimated completion is 2013-01-01.
Who is sponsoring clinical trial NCT00594451?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
- NCT03048201 · 800 participants · NA
Physica System Total Knee Replacement Registry Study
- NCT03792659 · 800 participants
The EXPLORE MG Registry for Myasthenia Gravis
- NCT03819296 · 800 participants · Phase 1
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI